| 1 |
34688813 | CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation. | 2022 Jan 30 |
4 |
| 2 |
33515077 | Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome. | 2021 Aug |
1 |
| 3 |
33649515 | Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients. | 2021 Jun |
1 |
| 4 |
32034192 | Author Correction: Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients. | 2020 Feb 7 |
1 |
| 5 |
31401678 | CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria. | 2019 Nov |
6 |
| 6 |
29629825 | CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administration. | 2018 Apr |
1 |
| 7 |
30156148 | Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A. | 2018 |
1 |
| 8 |
30584253 | Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients. | 2018 Dec 24 |
4 |